BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32342090)

  • 1. In vitro antiproliferative effect of vanadium complexes bearing 8-hydroxyquinoline-based ligands - the substituent effect.
    Choroba K; Raposo LR; Palion-Gazda J; Malicka E; Erfurt K; Machura B; Fernandes AR
    Dalton Trans; 2020 May; 49(20):6596-6606. PubMed ID: 32342090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
    Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
    Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanadium(IV) Complexes with Methyl-Substituted 8-Hydroxyquinolines: Catalytic Potential in the Oxidation of Hydrocarbons and Alcohols with Peroxides and Biological Activity.
    Palion-Gazda J; Luz A; Raposo LR; Choroba K; Nycz JE; Bieńko A; Lewińska A; Erfurt K; V Baptista P; Machura B; Fernandes AR; Shul'pina LS; Ikonnikov NS; Shul'pin GB
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
    Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
    Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
    Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
    J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Hydroxyquinoline derived p-halo N4-phenyl substituted thiosemicarbazones: Crystal structures, spectral characterization and in vitro cytotoxic studies of their Co(III), Ni(II) and Cu(II) complexes.
    Kotian A; Kamat V; Naik K; Kokare DG; Kumara K; Neratur KL; Kumbar V; Bhat K; Revankar VK
    Bioorg Chem; 2021 Jul; 112():104962. PubMed ID: 33992968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes.
    Ribeiro N; Bulut I; Pósa V; Sergi B; Sciortino G; Pessoa JC; Maia LB; Ugone V; Garribba E; Enyedy ÉA; Acilan C; Correia I
    J Inorg Biochem; 2022 Oct; 235():111932. PubMed ID: 35940023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopy, electrochemistry and antiproliferative properties of Au(iii), Pt(ii) and Cu(ii) complexes bearing modified 2,2':6',2''-terpyridine ligands.
    Maroń A; Czerwińska K; Machura B; Raposo L; Roma-Rodrigues C; Fernandes AR; Małecki JG; Szlapa-Kula A; Kula S; Krompiec S
    Dalton Trans; 2018 May; 47(18):6444-6463. PubMed ID: 29688241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
    Le M; Rathje O; Levina A; Lay PA
    J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic oxidovanadium(IV) complexes of tridentate halogen-substituted Schiff bases: First dinuclear V(IV) complexes with O → V
    Rudbari HA; Saadati A; Aryaeifar M; Correia I; Marques F; Blacque O; Micale N
    Bioorg Med Chem Lett; 2021 Oct; 49():128285. PubMed ID: 34303813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible Selective Cytotoxicity of Vanadium Complex on Breast Cancer Cells Involving Pathophysiological Pathways.
    El-Shafey ES; Elsherbiny ES
    Anticancer Agents Med Chem; 2019; 19(17):2130-2139. PubMed ID: 31696812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage induction and antiproliferative activity of vanadium(V) oxido monoperoxido complex containing two bidentate heteroligands.
    Andrezálová L; Gbelcová H; Duračková Z
    J Trace Elem Med Biol; 2013 Jan; 27(1):21-6. PubMed ID: 22575540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-recognition of the racemic ligand in the formation of homochiral dinuclear V(V) complex: In vitro anticancer activity, DNA and HSA interaction.
    Kazemi Z; Amiri Rudbari H; Mirkhani V; Sahihi M; Moghadam M; Tangestaninejad S; Mohammadpoor-Baltork I; Kajani AA; Azimi G
    Eur J Med Chem; 2017 Jul; 135():230-240. PubMed ID: 28456032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Potential In Vitro Modes of Action of Bis(β-diketonato) Oxovanadium(IV) Complexes.
    Sergi B; Bulut I; Xia Y; Waller ZAE; Yildizhan Y; Acilan C; Lord RM
    ChemMedChem; 2021 Aug; 16(15):2402-2410. PubMed ID: 33856120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, immunomodulation and cytotoxic effects of vanadium (IV) complexes.
    Ashiq U; Jamal RA; Mesaik MA; Mahroof-Tahir M; Shahid S; Khan KM
    Med Chem; 2014 May; 10(3):287-99. PubMed ID: 23876231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanadocene complexes bearing N,N'-chelating ligands: Synthesis, structures and in vitro cytotoxic studies on the A549 lung adenocarcinoma cell line.
    Melounková L; Machálková A; Havelek R; Honzíček J; Řezáčová M; Císařová I; Peterová E; Vinklárek J
    J Inorg Biochem; 2019 Jun; 195():182-193. PubMed ID: 30959320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral vanadium(V) complexes with 2-aminoglucose Schiff-base ligands and their solution configurations: synthesis, structures, and DFT calculations.
    Mohammadnezhad G; Böhme M; Geibig D; Burkhardt A; Görls H; Plass W
    Dalton Trans; 2013 Sep; 42(33):11812-23. PubMed ID: 23760018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells.
    Kowalski S; Tesmar A; Sikorski A; Inkielewicz-Stępniak I
    Anticancer Agents Med Chem; 2021; 21(1):71-83. PubMed ID: 32579508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
    Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
    Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.